Flecainide Improve Sepsis Induced Acute Lung Injury by Controlling Inflammatory Response

Background: Flecainide is an antiarrhythmic agent that is used primarily in the treatment of cardiac arrhythmias. Some evidences also suggest that flecainide can participate in alveolar fluid clearance and inflammatory responses. This experiment was aimed to evaluate the effects of flecainide on sep...

Full description

Bibliographic Details
Main Authors: Jia Song, Young joong Suh, Hyun jung Lee, Eun a Jang, Hong-beom Bae, Sang-Hyun Kwak
Format: Article
Language:English
Published: Korean Society of Critical Care Medicine 2016-08-01
Series:Korean Journal of Critical Care Medicine
Subjects:
Online Access:http://www.kjccm.org/upload/pdf/kjccm-2016-00157.pdf
_version_ 1818200706701590528
author Jia Song
Young joong Suh
Hyun jung Lee
Eun a Jang
Hong-beom Bae
Sang-Hyun Kwak
author_facet Jia Song
Young joong Suh
Hyun jung Lee
Eun a Jang
Hong-beom Bae
Sang-Hyun Kwak
author_sort Jia Song
collection DOAJ
description Background: Flecainide is an antiarrhythmic agent that is used primarily in the treatment of cardiac arrhythmias. Some evidences also suggest that flecainide can participate in alveolar fluid clearance and inflammatory responses. This experiment was aimed to evaluate the effects of flecainide on sepsis induced acute lung injury in a rat model. Methods: Rats were treated with subcutaneous infusion of saline or flecainide (0.1 or 0.2 mg/kg/hr) by a mini-osmotic pump. Subcutaneous infusion was started 3 hours before and continued until 8 hours after intraperitoneal injection of saline or endotoxin. Animals were sacrificed for analyses of severity of acute lung injury with wet to dry (W/D) ratio and lung injury score (LIS) in lung and inflammatory responses with level of leukocyte, polymorphonuclear neutrophils (PMNs) and inteleukin-8 (IL-8) in bronchoalveolar lavages fluid (BALF). Results: Flecainide markedly improved dose dependently sepsis induced acute lung injury as analysed by W/D ratio (from 2.24 ± 0.11 to 1.76 ± 0.09, p < 0.05) and LIS (from 3 to 1, p < 0.05), and inflammatory response as determined by leukocyte (from 443 ± 127 to 229 ± 95, p < 0.05), PMNs (from 41.43 ± 17.63 to 2.43 ± 2.61, p < 0.05) and IL-8 (from 95.00 ± 15.28 to 40.00 ± 10.21, p < 0.05) in BALF. Conclusions: Flecanide improve sepsis induced acute lung injury in rats by controlling inflammatory responses.
first_indexed 2024-12-12T02:41:56Z
format Article
id doaj.art-2e744755bf5245fab341c1e81ae9a170
institution Directory Open Access Journal
issn 2383-4870
2383-4889
language English
last_indexed 2024-12-12T02:41:56Z
publishDate 2016-08-01
publisher Korean Society of Critical Care Medicine
record_format Article
series Korean Journal of Critical Care Medicine
spelling doaj.art-2e744755bf5245fab341c1e81ae9a1702022-12-22T00:41:08ZengKorean Society of Critical Care MedicineKorean Journal of Critical Care Medicine2383-48702383-48892016-08-0131319420110.4266/kjccm.2016.001571036Flecainide Improve Sepsis Induced Acute Lung Injury by Controlling Inflammatory ResponseJia Song0Young joong Suh1Hyun jung Lee2Eun a Jang3Hong-beom Bae4Sang-Hyun Kwak5 Department of Anesthesiology and Pain Medicine, Chonnam National University Hospital, Chonnam National University Medical School, Korea Department of Anesthesiology and Pain Medicine, Gwangju Christian Hospital, Gwangju, Korea Department of Anesthesiology and Pain Medicine, Chonnam National University Hospital, Chonnam National University Medical School, Korea Department of Anesthesiology and Pain Medicine, Chonnam National University Hwasun Hospital, Hwasun, Korea Department of Anesthesiology and Pain Medicine, Chonnam National University Hwasun Hospital, Hwasun, Korea Department of Anesthesiology and Pain Medicine, Chonnam National University Hospital, Chonnam National University Medical School, KoreaBackground: Flecainide is an antiarrhythmic agent that is used primarily in the treatment of cardiac arrhythmias. Some evidences also suggest that flecainide can participate in alveolar fluid clearance and inflammatory responses. This experiment was aimed to evaluate the effects of flecainide on sepsis induced acute lung injury in a rat model. Methods: Rats were treated with subcutaneous infusion of saline or flecainide (0.1 or 0.2 mg/kg/hr) by a mini-osmotic pump. Subcutaneous infusion was started 3 hours before and continued until 8 hours after intraperitoneal injection of saline or endotoxin. Animals were sacrificed for analyses of severity of acute lung injury with wet to dry (W/D) ratio and lung injury score (LIS) in lung and inflammatory responses with level of leukocyte, polymorphonuclear neutrophils (PMNs) and inteleukin-8 (IL-8) in bronchoalveolar lavages fluid (BALF). Results: Flecainide markedly improved dose dependently sepsis induced acute lung injury as analysed by W/D ratio (from 2.24 ± 0.11 to 1.76 ± 0.09, p < 0.05) and LIS (from 3 to 1, p < 0.05), and inflammatory response as determined by leukocyte (from 443 ± 127 to 229 ± 95, p < 0.05), PMNs (from 41.43 ± 17.63 to 2.43 ± 2.61, p < 0.05) and IL-8 (from 95.00 ± 15.28 to 40.00 ± 10.21, p < 0.05) in BALF. Conclusions: Flecanide improve sepsis induced acute lung injury in rats by controlling inflammatory responses.http://www.kjccm.org/upload/pdf/kjccm-2016-00157.pdflung injurycytokineflecainideleukocytesepsis
spellingShingle Jia Song
Young joong Suh
Hyun jung Lee
Eun a Jang
Hong-beom Bae
Sang-Hyun Kwak
Flecainide Improve Sepsis Induced Acute Lung Injury by Controlling Inflammatory Response
Korean Journal of Critical Care Medicine
lung injury
cytokine
flecainide
leukocyte
sepsis
title Flecainide Improve Sepsis Induced Acute Lung Injury by Controlling Inflammatory Response
title_full Flecainide Improve Sepsis Induced Acute Lung Injury by Controlling Inflammatory Response
title_fullStr Flecainide Improve Sepsis Induced Acute Lung Injury by Controlling Inflammatory Response
title_full_unstemmed Flecainide Improve Sepsis Induced Acute Lung Injury by Controlling Inflammatory Response
title_short Flecainide Improve Sepsis Induced Acute Lung Injury by Controlling Inflammatory Response
title_sort flecainide improve sepsis induced acute lung injury by controlling inflammatory response
topic lung injury
cytokine
flecainide
leukocyte
sepsis
url http://www.kjccm.org/upload/pdf/kjccm-2016-00157.pdf
work_keys_str_mv AT jiasong flecainideimprovesepsisinducedacutelunginjurybycontrollinginflammatoryresponse
AT youngjoongsuh flecainideimprovesepsisinducedacutelunginjurybycontrollinginflammatoryresponse
AT hyunjunglee flecainideimprovesepsisinducedacutelunginjurybycontrollinginflammatoryresponse
AT eunajang flecainideimprovesepsisinducedacutelunginjurybycontrollinginflammatoryresponse
AT hongbeombae flecainideimprovesepsisinducedacutelunginjurybycontrollinginflammatoryresponse
AT sanghyunkwak flecainideimprovesepsisinducedacutelunginjurybycontrollinginflammatoryresponse